220 related articles for article (PubMed ID: 30913450)
1. A novel inhibitor of nuclear factor kappa-B kinase subunit gamma mutation identified in an incontinentia pigmenti patient with syndromic tooth agenesis.
Sun S; Li F; Liu Y; Qu H; Wong SW; Zeng L; Yu M; Feng H; Liu H; Han D
Arch Oral Biol; 2019 May; 101():100-107. PubMed ID: 30913450
[TBL] [Abstract][Full Text] [Related]
2. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
[TBL] [Abstract][Full Text] [Related]
3. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.
Conte MI; Pescatore A; Paciolla M; Esposito E; Miano MG; Lioi MB; McAleer MA; Giardino G; Pignata C; Irvine AD; Scheuerle AE; Royer G; Hadj-Rabia S; Bodemer C; Bonnefont JP; Munnich A; Smahi A; Steffann J; Fusco F; Ursini MV
Hum Mutat; 2014 Feb; 35(2):165-77. PubMed ID: 24339369
[TBL] [Abstract][Full Text] [Related]
4. Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.
Sebban-Benin H; Pescatore A; Fusco F; Pascuale V; Gautheron J; Yamaoka S; Moncla A; Ursini MV; Courtois G
Hum Mol Genet; 2007 Dec; 16(23):2805-15. PubMed ID: 17728323
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.
Gautheron J; Pescatore A; Fusco F; Esposito E; Yamaoka S; Agou F; Ursini MV; Courtois G
Hum Mol Genet; 2010 Aug; 19(16):3138-49. PubMed ID: 20529958
[TBL] [Abstract][Full Text] [Related]
6. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
[TBL] [Abstract][Full Text] [Related]
7. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
[TBL] [Abstract][Full Text] [Related]
8. The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.
Song MJ; Chae JH; Park EA; Ki CS
J Korean Med Sci; 2010 Oct; 25(10):1513-7. PubMed ID: 20890435
[TBL] [Abstract][Full Text] [Related]
9. An Atypical Incontinentia Pigmenti Female with Persistent Mucocutaneous Hyperinflammation and Immunodeficiency Caused by a Novel Germline IKBKG Missense Mutation.
Mou W; Zhao Z; Gao L; Fu L; Li J; Jiao A; Peng Y; Yu T; Guo Y; Chen L; Wang H; Liu J; Qin Q; Xu B; Liu X; He J; Gui J
J Clin Immunol; 2023 Nov; 43(8):2165-2180. PubMed ID: 37831401
[TBL] [Abstract][Full Text] [Related]
10. Unusual Father-to-Daughter Transmission of Incontinentia Pigmenti Due to Mosaicism in IP Males.
Fusco F; Conte MI; Diociaiuti A; Bigoni S; Branda MF; Ferlini A; El Hachem M; Ursini MV
Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28794079
[TBL] [Abstract][Full Text] [Related]
11. Incontinentia pigmenti in a male (XY) infant with long-term follow up over 8 years.
Matsuzaki Y; Rokunohe A; Minakawa S; Nomura K; Nakano H; Ito E; Sawamura D
J Dermatol; 2018 Jan; 45(1):100-103. PubMed ID: 28791733
[TBL] [Abstract][Full Text] [Related]
12. Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms.
Fusco F; Paciolla M; Napolitano F; Pescatore A; D'Addario I; Bal E; Lioi MB; Smahi A; Miano MG; Ursini MV
Hum Mol Genet; 2012 Mar; 21(6):1260-71. PubMed ID: 22121116
[TBL] [Abstract][Full Text] [Related]
13. Absence of an osteopetrosis phenotype in IKBKG (NEMO) mutation-positive women: A case-control study.
Frost M; Tencerova M; Andreasen CM; Andersen TL; Ejersted C; Svaneby D; Qui W; Kassem M; Zarei A; McAlister WH; Veis DJ; Whyte MP; Frederiksen AL
Bone; 2019 Apr; 121():243-254. PubMed ID: 30659980
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation.
Fusco F; Bardaro T; Fimiani G; Mercadante V; Miano MG; Falco G; Israël A; Courtois G; D'Urso M; Ursini MV
Hum Mol Genet; 2004 Aug; 13(16):1763-73. PubMed ID: 15229184
[TBL] [Abstract][Full Text] [Related]
15. A novel IKBKG mutation in a patient with incontinentia pigmenti and features of hepatic ciliopathy.
Danescu S; Has C; Baican C; Müller T; Baican A
Australas J Dermatol; 2018 Nov; 59(4):e262-e265. PubMed ID: 29520766
[TBL] [Abstract][Full Text] [Related]
16. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
Ramírez-Alejo N; Alcántara-Montiel JC; Yamazaki-Nakashimada M; Duran-McKinster C; Valenzuela-León P; Rivas-Larrauri F; Cedillo-Barrón L; Hernández-Rivas R; Santos-Argumedo L
Clin Immunol; 2015 Oct; 160(2):163-71. PubMed ID: 26117626
[TBL] [Abstract][Full Text] [Related]
17. A Novel Frameshift Mutation of the IKBKG Gene Causing Typical Incontinentia Pigmenti.
Minić S; Trpinac D; Obradović M
Srp Arh Celok Lek; 2015; 143(11-12):752-4. PubMed ID: 26946775
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations.
Fusco F; Pescatore A; Bal E; Ghoul A; Paciolla M; Lioi MB; D'Urso M; Rabia SH; Bodemer C; Bonnefont JP; Munnich A; Miano MG; Smahi A; Ursini MV
Hum Mutat; 2008 May; 29(5):595-604. PubMed ID: 18350553
[TBL] [Abstract][Full Text] [Related]
19. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.
Matta H; Gopalakrishnan R; Graham C; Tolani B; Khanna A; Yi H; Suo Y; Chaudhary PM
PLoS One; 2012; 7(5):e36601. PubMed ID: 22590573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
